The Journal of Pediatrics
Volume 148, Issue 5 , Pages 623-627.e3 , May 2006

Rituximab therapy for childhood-onset systemic lupus erythematosus

  • M. Willems, MD

      Affiliations

    • Department of Pediatrics, Hôpital de Bicêtre, Le Kremlin Bicêtre, France
    • Immuno-Allergy and Rheumatology Unit, CHU Sainte-Justine, Mother and Child University Hospital Center, Universite de Montreal, Montreal, Quebec, Canada
    • Department of Pediatric Nephrology, Hôpital Necker, Paris, France; Department of Pediatric Nephrology, Hôpital Trousseau, Paris, France
    • Department of Pediatric Nephrology, Hôpital Edouard-Herriot, Lyon, France; Department of Nephrology, Hôpital Necker, Paris, France
    • Department of Pediatric Hematology, Hôpital Saint Louis, Paris, France
    • Department of Pediatrics, Hôpital Pellegrin, Bordeaux, France
    • Department of Pediatric Nephrology, Hôpital R. Debré, Paris, France
  • ,
  • E. Haddad, MD, PhD

      Affiliations

    • Department of Pediatrics, Hôpital de Bicêtre, Le Kremlin Bicêtre, France
    • Immuno-Allergy and Rheumatology Unit, CHU Sainte-Justine, Mother and Child University Hospital Center, Universite de Montreal, Montreal, Quebec, Canada
    • Department of Pediatric Nephrology, Hôpital Necker, Paris, France; Department of Pediatric Nephrology, Hôpital Trousseau, Paris, France
    • Department of Pediatric Nephrology, Hôpital Edouard-Herriot, Lyon, France; Department of Nephrology, Hôpital Necker, Paris, France
    • Department of Pediatric Hematology, Hôpital Saint Louis, Paris, France
    • Department of Pediatrics, Hôpital Pellegrin, Bordeaux, France
    • Department of Pediatric Nephrology, Hôpital R. Debré, Paris, France
  • ,
  • P. Niaudet, MD

      Affiliations

    • Department of Pediatrics, Hôpital de Bicêtre, Le Kremlin Bicêtre, France
    • Immuno-Allergy and Rheumatology Unit, CHU Sainte-Justine, Mother and Child University Hospital Center, Universite de Montreal, Montreal, Quebec, Canada
    • Department of Pediatric Nephrology, Hôpital Necker, Paris, France; Department of Pediatric Nephrology, Hôpital Trousseau, Paris, France
    • Department of Pediatric Nephrology, Hôpital Edouard-Herriot, Lyon, France; Department of Nephrology, Hôpital Necker, Paris, France
    • Department of Pediatric Hematology, Hôpital Saint Louis, Paris, France
    • Department of Pediatrics, Hôpital Pellegrin, Bordeaux, France
    • Department of Pediatric Nephrology, Hôpital R. Debré, Paris, France
  • ,
  • I. Koné-Paut, MD

      Affiliations

    • Department of Pediatrics, Hôpital de Bicêtre, Le Kremlin Bicêtre, France
    • Immuno-Allergy and Rheumatology Unit, CHU Sainte-Justine, Mother and Child University Hospital Center, Universite de Montreal, Montreal, Quebec, Canada
    • Department of Pediatric Nephrology, Hôpital Necker, Paris, France; Department of Pediatric Nephrology, Hôpital Trousseau, Paris, France
    • Department of Pediatric Nephrology, Hôpital Edouard-Herriot, Lyon, France; Department of Nephrology, Hôpital Necker, Paris, France
    • Department of Pediatric Hematology, Hôpital Saint Louis, Paris, France
    • Department of Pediatrics, Hôpital Pellegrin, Bordeaux, France
    • Department of Pediatric Nephrology, Hôpital R. Debré, Paris, France
  • ,
  • A. Bensman, MD

      Affiliations

    • Department of Pediatrics, Hôpital de Bicêtre, Le Kremlin Bicêtre, France
    • Immuno-Allergy and Rheumatology Unit, CHU Sainte-Justine, Mother and Child University Hospital Center, Universite de Montreal, Montreal, Quebec, Canada
    • Department of Pediatric Nephrology, Hôpital Necker, Paris, France; Department of Pediatric Nephrology, Hôpital Trousseau, Paris, France
    • Department of Pediatric Nephrology, Hôpital Edouard-Herriot, Lyon, France; Department of Nephrology, Hôpital Necker, Paris, France
    • Department of Pediatric Hematology, Hôpital Saint Louis, Paris, France
    • Department of Pediatrics, Hôpital Pellegrin, Bordeaux, France
    • Department of Pediatric Nephrology, Hôpital R. Debré, Paris, France
  • ,
  • P. Cochat, MD, PhD

      Affiliations

    • Department of Pediatrics, Hôpital de Bicêtre, Le Kremlin Bicêtre, France
    • Immuno-Allergy and Rheumatology Unit, CHU Sainte-Justine, Mother and Child University Hospital Center, Universite de Montreal, Montreal, Quebec, Canada
    • Department of Pediatric Nephrology, Hôpital Necker, Paris, France; Department of Pediatric Nephrology, Hôpital Trousseau, Paris, France
    • Department of Pediatric Nephrology, Hôpital Edouard-Herriot, Lyon, France; Department of Nephrology, Hôpital Necker, Paris, France
    • Department of Pediatric Hematology, Hôpital Saint Louis, Paris, France
    • Department of Pediatrics, Hôpital Pellegrin, Bordeaux, France
    • Department of Pediatric Nephrology, Hôpital R. Debré, Paris, France
  • ,
  • G. Deschênes, MD, PhD

      Affiliations

    • Department of Pediatrics, Hôpital de Bicêtre, Le Kremlin Bicêtre, France
    • Immuno-Allergy and Rheumatology Unit, CHU Sainte-Justine, Mother and Child University Hospital Center, Universite de Montreal, Montreal, Quebec, Canada
    • Department of Pediatric Nephrology, Hôpital Necker, Paris, France; Department of Pediatric Nephrology, Hôpital Trousseau, Paris, France
    • Department of Pediatric Nephrology, Hôpital Edouard-Herriot, Lyon, France; Department of Nephrology, Hôpital Necker, Paris, France
    • Department of Pediatric Hematology, Hôpital Saint Louis, Paris, France
    • Department of Pediatrics, Hôpital Pellegrin, Bordeaux, France
    • Department of Pediatric Nephrology, Hôpital R. Debré, Paris, France
  • ,
  • F. Fakhouri, MD

      Affiliations

    • Department of Pediatrics, Hôpital de Bicêtre, Le Kremlin Bicêtre, France
    • Immuno-Allergy and Rheumatology Unit, CHU Sainte-Justine, Mother and Child University Hospital Center, Universite de Montreal, Montreal, Quebec, Canada
    • Department of Pediatric Nephrology, Hôpital Necker, Paris, France; Department of Pediatric Nephrology, Hôpital Trousseau, Paris, France
    • Department of Pediatric Nephrology, Hôpital Edouard-Herriot, Lyon, France; Department of Nephrology, Hôpital Necker, Paris, France
    • Department of Pediatric Hematology, Hôpital Saint Louis, Paris, France
    • Department of Pediatrics, Hôpital Pellegrin, Bordeaux, France
    • Department of Pediatric Nephrology, Hôpital R. Debré, Paris, France
  • ,
  • T. Leblanc, MD

      Affiliations

    • Department of Pediatrics, Hôpital de Bicêtre, Le Kremlin Bicêtre, France
    • Immuno-Allergy and Rheumatology Unit, CHU Sainte-Justine, Mother and Child University Hospital Center, Universite de Montreal, Montreal, Quebec, Canada
    • Department of Pediatric Nephrology, Hôpital Necker, Paris, France; Department of Pediatric Nephrology, Hôpital Trousseau, Paris, France
    • Department of Pediatric Nephrology, Hôpital Edouard-Herriot, Lyon, France; Department of Nephrology, Hôpital Necker, Paris, France
    • Department of Pediatric Hematology, Hôpital Saint Louis, Paris, France
    • Department of Pediatrics, Hôpital Pellegrin, Bordeaux, France
    • Department of Pediatric Nephrology, Hôpital R. Debré, Paris, France
  • ,
  • B. Llanas, MD

      Affiliations

    • Department of Pediatrics, Hôpital de Bicêtre, Le Kremlin Bicêtre, France
    • Immuno-Allergy and Rheumatology Unit, CHU Sainte-Justine, Mother and Child University Hospital Center, Universite de Montreal, Montreal, Quebec, Canada
    • Department of Pediatric Nephrology, Hôpital Necker, Paris, France; Department of Pediatric Nephrology, Hôpital Trousseau, Paris, France
    • Department of Pediatric Nephrology, Hôpital Edouard-Herriot, Lyon, France; Department of Nephrology, Hôpital Necker, Paris, France
    • Department of Pediatric Hematology, Hôpital Saint Louis, Paris, France
    • Department of Pediatrics, Hôpital Pellegrin, Bordeaux, France
    • Department of Pediatric Nephrology, Hôpital R. Debré, Paris, France
  • ,
  • C. Loirat, MD

      Affiliations

    • Department of Pediatrics, Hôpital de Bicêtre, Le Kremlin Bicêtre, France
    • Immuno-Allergy and Rheumatology Unit, CHU Sainte-Justine, Mother and Child University Hospital Center, Universite de Montreal, Montreal, Quebec, Canada
    • Department of Pediatric Nephrology, Hôpital Necker, Paris, France; Department of Pediatric Nephrology, Hôpital Trousseau, Paris, France
    • Department of Pediatric Nephrology, Hôpital Edouard-Herriot, Lyon, France; Department of Nephrology, Hôpital Necker, Paris, France
    • Department of Pediatric Hematology, Hôpital Saint Louis, Paris, France
    • Department of Pediatrics, Hôpital Pellegrin, Bordeaux, France
    • Department of Pediatric Nephrology, Hôpital R. Debré, Paris, France
  • ,
  • P. Pillet, MD

      Affiliations

    • Department of Pediatrics, Hôpital de Bicêtre, Le Kremlin Bicêtre, France
    • Immuno-Allergy and Rheumatology Unit, CHU Sainte-Justine, Mother and Child University Hospital Center, Universite de Montreal, Montreal, Quebec, Canada
    • Department of Pediatric Nephrology, Hôpital Necker, Paris, France; Department of Pediatric Nephrology, Hôpital Trousseau, Paris, France
    • Department of Pediatric Nephrology, Hôpital Edouard-Herriot, Lyon, France; Department of Nephrology, Hôpital Necker, Paris, France
    • Department of Pediatric Hematology, Hôpital Saint Louis, Paris, France
    • Department of Pediatrics, Hôpital Pellegrin, Bordeaux, France
    • Department of Pediatric Nephrology, Hôpital R. Debré, Paris, France
  • ,
  • B. Ranchin, MD

      Affiliations

    • Department of Pediatrics, Hôpital de Bicêtre, Le Kremlin Bicêtre, France
    • Immuno-Allergy and Rheumatology Unit, CHU Sainte-Justine, Mother and Child University Hospital Center, Universite de Montreal, Montreal, Quebec, Canada
    • Department of Pediatric Nephrology, Hôpital Necker, Paris, France; Department of Pediatric Nephrology, Hôpital Trousseau, Paris, France
    • Department of Pediatric Nephrology, Hôpital Edouard-Herriot, Lyon, France; Department of Nephrology, Hôpital Necker, Paris, France
    • Department of Pediatric Hematology, Hôpital Saint Louis, Paris, France
    • Department of Pediatrics, Hôpital Pellegrin, Bordeaux, France
    • Department of Pediatric Nephrology, Hôpital R. Debré, Paris, France
  • ,
  • R. Salomon, MD, PhD

      Affiliations

    • Department of Pediatrics, Hôpital de Bicêtre, Le Kremlin Bicêtre, France
    • Immuno-Allergy and Rheumatology Unit, CHU Sainte-Justine, Mother and Child University Hospital Center, Universite de Montreal, Montreal, Quebec, Canada
    • Department of Pediatric Nephrology, Hôpital Necker, Paris, France; Department of Pediatric Nephrology, Hôpital Trousseau, Paris, France
    • Department of Pediatric Nephrology, Hôpital Edouard-Herriot, Lyon, France; Department of Nephrology, Hôpital Necker, Paris, France
    • Department of Pediatric Hematology, Hôpital Saint Louis, Paris, France
    • Department of Pediatrics, Hôpital Pellegrin, Bordeaux, France
    • Department of Pediatric Nephrology, Hôpital R. Debré, Paris, France
  • ,
  • T. Ulinski, MD

      Affiliations

    • Department of Pediatrics, Hôpital de Bicêtre, Le Kremlin Bicêtre, France
    • Immuno-Allergy and Rheumatology Unit, CHU Sainte-Justine, Mother and Child University Hospital Center, Universite de Montreal, Montreal, Quebec, Canada
    • Department of Pediatric Nephrology, Hôpital Necker, Paris, France; Department of Pediatric Nephrology, Hôpital Trousseau, Paris, France
    • Department of Pediatric Nephrology, Hôpital Edouard-Herriot, Lyon, France; Department of Nephrology, Hôpital Necker, Paris, France
    • Department of Pediatric Hematology, Hôpital Saint Louis, Paris, France
    • Department of Pediatrics, Hôpital Pellegrin, Bordeaux, France
    • Department of Pediatric Nephrology, Hôpital R. Debré, Paris, France
  • ,
  • Brigitte Bader-Meunier, MD

      Affiliations

    • Department of Pediatrics, Hôpital de Bicêtre, Le Kremlin Bicêtre, France
    • Immuno-Allergy and Rheumatology Unit, CHU Sainte-Justine, Mother and Child University Hospital Center, Universite de Montreal, Montreal, Quebec, Canada
    • Department of Pediatric Nephrology, Hôpital Necker, Paris, France; Department of Pediatric Nephrology, Hôpital Trousseau, Paris, France
    • Department of Pediatric Nephrology, Hôpital Edouard-Herriot, Lyon, France; Department of Nephrology, Hôpital Necker, Paris, France
    • Department of Pediatric Hematology, Hôpital Saint Louis, Paris, France
    • Department of Pediatrics, Hôpital Pellegrin, Bordeaux, France
    • Department of Pediatric Nephrology, Hôpital R. Debré, Paris, France
    • Corresponding Author InformationReprint requests: Brigitte Bader-Meunier, Service de Pédiatrie générale, Hôpital de Bicêtre, 78 rue du Général Leclerc, 94276 Le Kremlin Bicêtre, France
  • ,
  • French pediatric-onset SLE study group

      Affiliations

    • Complete list of participating centers is available at www.jpeds.com

Received 18 July 2005 ,Revised 12 December 2005 ,Accepted 20 January 2006.

References 

  1. Bader-Meunier B , Armengaud JB , Haddad E , Salomon R , Deschênes G , Koné-Paut I , et al.   Initial presentation of childhood-onset systemic lupus erythematosus (a French multicenter study) . J Pediatr . 2005;146:648–653
  2. Carreno L , Lopez-Longo FJ , Monteagudo I , Rodriguez-Mahou M , Bascones M , Gonzalez CM , et al.   Immunological and clinical differencies between juvenile and adult onset of systemic lupus erythematosus . Lupus . 1999;8:287–292
  3. Carreno L , Lopez-Longo FJ , Gonzalez CM , Monteagudo I . Treatment options for juvenile-onset systemic lupus erythematosus . Pediatr Drugs . 2002;4:241–256
  4. Lipsky PE. Systemic lupus erythematosus : an autoimmune disease of B cell hyperactivity. Nat Immunol 200;2:764-6.
  5. Grammer AC , Lipsky PE . B cell abnormalities in systemic lupus erythematosus . Arthritis Res Ther . 2003;5(suppl 4):S22–S27
  6. Chan OT , Hannum LG , Haberman AM , Madaio MP , Shlomchik MJ . A novel mouse with B cells but lacking serum antibody reveals an antibody-indepedent role of B cells in murine lupus . J Exp Med . 1999;189:1639–1648
  7. Looney RJ . Treating human autoimmune disease by depleting B cells . Ann Rheum Dis . 2002;61:863–866
  8. Silverman GJ . Anti-CD20 therapy in systemic lupus erythematosus (a step closer to the clinic) . Arthritis Rheum . 2005;52:371–377
  9. Johnson PW , Glennie MJ . Rituximab (mechanisms and applications) . Br J Cancer . 2001;85:1619–1623
  10. Sfikakis PP , Boletis JN , Lionaki S , Vigklis V , Fragiadaki KG , Iniotaki A , et al.   Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand (an open-label trial) . Arthritis Rheum . 2005;52:501–513
  11. Looney RJ , Anolik JH , Campbell D , Felgar RE , Young F , Arend LJ , et al.   B cell depletion as a novel treatment for systemic lupus erythematosus (a phase I/II dose-escalation trial of rituximab) . Arthritis Rheum . 2004;50:2580–2589
  12. Leandro MJ , Edwards JC , Cambridge G , Ehrenstein MR , Isenberg DA . An open study of B lymphocyte depletion in systemic lupus erythematosus . Arthritis Rheum . 2002;46:2673–2677
  13. Leandro MJ , Cambridge G , Edwards JC , Ehrenstein MR , Isenberg DA . B-cell depletion in the treatment of patients with systemic lupus erythematosus (a longitudinal analysis of 24 patients) . Rheumatology (Oxford) . 2005;44:1542–1545
  14. Sfikakis PP , Boletis JN , Tsokos GC . Rituximab anti-B-cell therapy in systemic lupus erythematosus (pointing to the future) . Curr Opin Rheumatol . 2005;17:550–557
  15. Anolik JH , Campbell D , Felgar RE , Young F , Sanz I , Rosenblatt J , et al.   The relationship of FcγRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus . Arthritis Rheum . 2003;48:455–459
  16. Manger K , Repp R , Jansen M , Geisselbrecht M , Wassmuth R , Westerdaal NAC , et al.   Fcγ receptor IIa, IIIa, and IIIb polymorphisms in German patients with systemic lupus erythematosus (association with clinical symptoms) . Ann Rheum Dis . 2002;61:786–792
  17. Weening JJ , D’Agati VD , Schwartz MM , Seshan SV , Alpers CE , Appel GB , et al.   The classification of glomerulonephritis in systemic lupus erythematosus revisited . J Am Soc Nephrol . 2004;15:241–250
  18. Zecca M , Nobili B , Ramenghi U , Perrotta S , Amendola G , Rosito P , et al.   Rituximab for the treatment of refractory autoimmune hemolytic anemia in children . Blood . 2003;101:3857–3861
  19. Quartier P , Brethon B , Phillippet P , Landman-Parker J , Le Deist F , Fischer A . Treatment of childhood autoimmune haemolytic anemia with rituximab . Lancet . 2001;358:1511–1513
  20. Wang J , Wiley JM , Luddy R , Greenberg J , Feuerstein MA , Bussel JB . Chronic immune thrombocytopenic purpura in children (assessment of rituximab treatment) . J Pediatr . 2005;146:217–221
  21. Wylam ME , Peter M , Anderson PM , Kuntz NL , Rodriguez V . Successful treatment of refractory myasthenia gravis using rituximab (a pediatric case report) . J Pediatr . 2003;143:674–677
  22. Binstadt BA , Caldas A , Turvey S , Weinstein HJ , Jackson J Fulhbrigge RC , et al.   Rituximab therapy for multisystem autoimmune diseases in pediatric patient . J Pediatr . 2003;143:598–604
  23. Perotta S , Locatelli F , La Manna A , Cennamo L , De Stefano P , Nobili B . Anti-CD20 monoclonal antibody (rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus . Br J Hematol . 2002;116:465–467
  24. Cate R , Smiers FJ , Bredius RGM , Lankester AC , Van Suijlekom-Smit LWA , Huizinga TW , et al.   Anti-CD20 monoclonal antibody (rituximab) for refractory autoimmune thrombocytopenia in a girl with systemic lupus erythematosus . Rheumatology . 2004;43:244
  25. Marks SD , Patey S , Brogan PA , Hasson N , Pilkington C , Woo P , et al.   B lymphocyte depletion therapy in children with refractory systemic lupus erythematosus . Arthritis Rheum . 2005;52:3168–3174
  26. Edelbauer M , Jungraithmayr T , Zimmerhackl LB . Rituximab in childhood systemic lupus erythematosus refractory to conventional immunosuppression . Pediatr Nephrol . 2005;20:811–813
  27. Kneitz C , Wilhelm M , Tony HP . Effective B cell depletion with Rituximab in the treatment of autoimmune diseases . Immunobiology . 2002;206:519–527
  28. Gottenberg JE , Guillevin L , Lambotte O , Combe B , Allanore Y , Cantagrel  , et al.   Tolerance and short-term efficacy of rituximab in 43 patients with systemic autoimmune diseases . Ann Rheum Dis . 2005;64:913–920
  29. Van Vollenhoven RF , Gunnarson I , Welin-Henriksson E , Sundelin B , Osenberg A , Jacobson SHJ , et al.   Biopsy-verified response of severe lupus nephritis to treatment with rituximab (anti-CD20 monoclonal antibody) plus cyclophosphamide after biopsy documented failure to respons to cyclophosphamide alone . Scand J Rheumatol . 2004;33:423–427
  30. Ahn ER , Lander G , Bidot CJ , Jy W , Ahn YS . Long-term remission from life-threatening hypercoagulable state associated with lupus anticoagulant (LA) following rituximab therapy . Am J Hematol . 2005;78:127–129
  31. Weide R , Heymanns J , Pandorf A , Koppler H . Successful long-term treatment of systemic lupus erythematosus with rituximab maintenance therapy . Lupus . 2003;12:779–782
  32. Erdozain JG , Ruiz-Irastorza G , Egurbide MV , Aguirre C . Sustained response to rituximab of autoimmune haemolytic anemia associated with antiphospholipid syndrome . Haematologica . 2004;84:ECR34
  33. Harner KC , Jackson LW , Drabick JJ . Normalization of anticardiolipin antibodies following rituximab therapy for marginal zone lymphoma in a patient with Sjogren syndrome . Rheumatology . 2004;43:1310–1311
  34. Olgino TJ , Dalrymple SA . Targeting B cells for the treatment of rheumatoid arthritis . Arthritis Res Ther . 2003;5:S7–S11
  35. Jacobi AM , Odendahl M , Reiter K , Bruns A , Burmester GR , Radbruch A , et al.   Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus . Arthritis Rheum . 2003;48:1332–1342
  36. Silverman GJ , Weisman S . Rituximab therapy and autoimmune disorders (prospects for anti-B cell therapy) . Arthritis Rheum . 2003;48:1484–1492
  37. Kennedy AD, Solga MD, Schuman TA, Chi AW, Lindorfer MA, Sutherland WM, et al. An anti-C3b(i) mAb enhances complement activation, C3b(i) deposition, and killing of CD20+ cells by rituximab . Blood . 2003;101:1071–1079
  38. Anolik JH, Barnard J, Cappione A, Pugh-Bernard AE, Felgar RE, Looney RJ, et al. Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus . Arthritis Rheum . 2004;50:3580–3590

 Supported by a grant from the Association française pour le syndrome d’Evans.

PII: S0022-3476(06)00069-2

doi: 10.1016/j.jpeds.2006.01.041

The Journal of Pediatrics
Volume 148, Issue 5 , Pages 623-627.e3 , May 2006